Guided Therapeutics, Inc.
GTHP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,417 | -$3,489 | -$4,341 | -$2,071 |
| Dep. & Amort. | $95 | $85 | $72 | $83 |
| Deferred Tax | $0 | $0 | $0 | $223 |
| Stock-Based Comp. | $120 | $1,806 | $1,381 | $228 |
| Change in WC | $1,003 | -$105 | $548 | $78 |
| Other Non-Cash | $80 | -$43 | $861 | -$133 |
| Operating Cash Flow | -$1,119 | -$1,746 | -$1,478 | -$1,592 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$31 | -$14 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$31 | -$14 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $110 | -$412 | -$540 | $1,248 |
| Stock Issued | $835 | $436 | $1,392 | $2,100 |
| Stock Repurch. | $0 | $0 | $0 | -$125 |
| Dividends Paid | -$174 | $0 | $0 | $0 |
| Other Fin. Act. | $145 | $436 | $2,328 | $2,794 |
| Financing Cash Flow | $916 | $24 | $3,180 | $2,067 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$203 | -$1,722 | $1,671 | $461 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $591 | $2,313 | $643 | $182 |
| End Cash | $388 | $591 | $2,314 | $643 |
| Free Cash Flow | -$1,119 | -$1,746 | -$1,509 | -$1,606 |